Figure 4.
Nanodroplet characterization: (A) schematic of drug-loaded lipid shell composed of 1,2-dihexadecanoyl-sn-glycero-3-phosphate (DPPA), 1,2-dipalmitoryl-sn-glycero-3-phosphoethanolamine conjugated polyethylene glycol (MPEG5000 DPPE) and 1,2-dipalmitoyl-sn-glycero-3-phosphocholine (DPPC), (B) nanodroplet size distribution by nanoparticle tracking analysis at 1:10 dilution (n=3) with example brightfield image (scale bar 10 μm), (C) resultant microbubble size distribution measured by Coulter Counter (n=3) with example brightfield image (scale bar 10 μm), (D) spontaneous drug release measured in storage conditions of 4°C, 23°C, 37°C, (E) acoustic vaporization threshold in vitro shown through ultraharmonic emissions (black) alongside percentage of pentobarbital released (red) at increasing sonication pressures (n=6), (F) and comparison of vaporization pressures in vitro and in vivo (n=8), error bars show one standard deviation.
